S-adenosylmethionine synthetase is overexpressed in murine neuroblastoma cells resistant to nucleoside analogue inhibitors of S-adenosylhomocysteine hydrolase: A novel mechanism of drug resistance

Cancer Research

Volumn 59, Issue 8, 1999, Pages 1852-1856

  Dwivedi, Rama S ^a   Wang, Ling Jia ^a   Mirkin, Bernard L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSYLHOMOCYSTEINASE; METHIONINE ADENOSYLTRANSFERASE; NUCLEOSIDE ANALOG; S ADENOSYLHOMOCYSTEINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; MOUSE; MULTIDRUG RESISTANCE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE; ADENOSYLHOMOCYSTEINASE; ANIMALS; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; GENE EXPRESSION; HELA CELLS; HUMANS; HYDROLASES; METHIONINE ADENOSYLTRANSFERASE; MICE; NEUROBLASTOMA; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033561556     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hamre, M. R., Clark, S. H., and Mirkin, B. L. Resistance to inhibitors of S-adenosyl-L-homocysteine hydrolase in C1300 murine neuroblastoma tumor cells is associated with increased methionine adenosyltransferase activity. Oncol Res., 7: 487-492, 1995.
2. Chiang, P. K., Gordon, R. K., Tal, J., Zeng, G. C., Doctor, B. P., Pardhasardhi, K., and McCann, P. P. S-Adenosylmethionine and methylation. FASEB J., 10: 471-480, 1996.
3. Kotb, M., Mudd, S. H., Mato, J. M., Geller, A. M., Kredich, N. M., Chou, J. Y., and Cantoni, G. L. Consensus nomenclature for the mammalian methionine adenosyltransferase gene and gene products. Trends Genet., 13: 51-52, 1997.
4. Kotb, M., and Geller, A. M. Methionine adenosyltransferase: structure and function., Pharmacol. Ther., 59: 125-143, 1993.
5. Gil, B., Casado, M., Pajares, M. A., Bosca', L., Mato, J. M., Martin-Sanz, P., and Alvarez, L. Differential expression pattern of S-adenosylmethionine synthetase isozymes during rat liver development., Hepatology, 24: 876-881, 1996.
6. Tsukada, K., and Okada, G. S-Adenosylmethionine synthetase isozyme patterns from rat hepatoma induced by N-2-fluorenylacetamide. Biochem. Biophys. Res. Commun., 94: 1078-1082, 1980.
7. Cai, J., Mao, Z., Hwang. J-J., and Lu, S. C. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells. Cancer Res., 58: 1444-1450, 1998.
8. Alton, P. A., and Harris, A. L. Annotation. The role of DNA topoisomerases II in drug resistance. Br. J. Haematol., 85: 241-245, 1993.
9. Nyce, J. W. Drug-induced DNA hypermethylation and drug resistance in human tumors. Cancer Res., 49: 5829-5836, 1989.
10. Costello, J. F., Futscher, B. W., Kroes, R. A., and Pieper, R. O. Methylation related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of O-6-methylguanine DNA methyltransferase gene in human glioma cell lines. Mol. Cell Biol., 14: 6515-6521, 1994.
11. LeGros, H. L., Geller, A. M., and Kotb, M. Differential regulation of methionine adenosyltransferase in superantigen and mitogen stimulated human T lymphocytes. J. Biol. Chem., 272.-16040-16047, 1997.
12. Horikawa, S., and Tsukada, K. Molecular cloning and developmental expression of a human kidney S-adenosylmethionine synthelase. FEBS Lett., 312: 37-41, 1992.
13. Tso, J. Y., Sun, X-H., Kao, T-H., Reece, K. S., and Wu, R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAase: genomic complexity and molecular evolution of the gene. Nucleic Acids Res., 13: 2485-2502, 1985.
14. Yoder, J. A., Yen, R. C., Vertino, P. M., Bestor, T. H., and Baylin, S. B. New 5′ regions of the murine and human genes for DNA (cytosine-5)-methyltransferase. J. Biol. Chem., 271: 31092-31097, 1996.
15. Bradley, G., and Ling, V. P-glycoprotein, multidrug resistance and tumor progression. Cancer Metastasis Rev., 13: 223-233, 1994.
16. Bates, S. E., Mickley, L. A., Chen, Y-N., Richert, N., Rudick, J., Biedler, J. L., and Fojo, A. T. Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation. Mol. Cell. Biol., 9: 4337-4344, 1989.
17. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurtz, E. U., Duncan, A. M. V., and Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington DC), 258: 1650-1654, 1992.
18. Norris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Conn, S. L., and Haber, M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N. Engl. J. Med., 334: 231-238, 1996.
19. Ling, V. P-glycoprotein: its role in drug resistance. Am. J. Med., 99 (Suppl. 6A): 31S-34S, 1995.
20. Gonzalgo, M. L., and Jones, P. A. Mutagenic and epigenetic effects of DNA methylation. Mutat. Res., 386: 107-118, 1997.
21. Mol, C. D., Arvai, A. S., Slupphaug, G., Kavli, B., Alseth, I., Krokan, H. E., and Tainer, J. A. Crystal structure and mutational analysis of human uracil:DNA glycosylase: structural basis for specificity and catalysis. Cell, 80: 869-878, 1995.
22. Schmutte, C., Yang, A. S., Beart, R. W., and Jones, P. A. Base excision repair of U:G mismatches at a mutational hotspot in the p53 gene is more efficient than base excision repair of T:G mismatches in extracts of human colon tumors. Cancer Res., 55: 3742-3746, 1995.
23. Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., and Dryja, T. P. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene., Am. J. Hum. Genet., 48: 880-888, 1991.
24. Cedar, H. DNA methylation and gene activity. Cell, 53: 3-4, 1988.
25. Nyce, J. W. Gene silencing in mammalian cells by direct incorporation of electroporated 5-methyl-2′deoxycytidine 5′-triphosphate. Somatic Cell Mol. Genet., 17: 543-550, 1991.
26. Bellon, S. F., Coleman, J. H., and Lippard, S. J. DNA unwinding produced by site-specific intrastrand cross-links of the anticancer drug cis-diamminedichloroplatnum(II). Biochemistry, 30: 8026-8035, 1991.
27. Gnara, J. R., Tory, K., and Weng, Y. Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat. Genet., 7: 85-90, 1994.
28. Steenman, M. J. C., Rainier, S., Dobry, C. J., Grundy, P., Horon, I. L., and Feinberg, A. P. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilm's tumor. Nat. Genet., 7: 433-439, 1994.
29. Levine, A., Cantoni, G. L., and Razin, A. Methylation in the preinitiation domain suppresses gene transcription by an indirect mechanism. Proc. Natl. Acad. Sci. USA, 89: 10119-10123, 1992.
30. Nyce, J., Leonard, S., Canupp, D., Schulz, S., and Wong, S. Epigenetic mechanisms of drug resistance: drug-induced DNA hypermethylation and drug resistance. Proc. Natl. Acad. Sci. USA, 90: 2960-2964, 1993.